spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  OvaTure 

 HSMN NewsFeed - 6 Jan 2016
OvaScience Names Harald F. Stock Chief Executive Officer-Elect
Devices Personnel
 HSMN NewsFeed - 13 Jan 2014
OvaScience Provides Update on Pipeline Advancements and Commercial Plans; New Potential Fertility Treatment OvaPrime(SM) to Launch in 2015
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2014
OvaScience Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Marshall Edwards Appoints New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2009
Marshall Edwards, Inc. Granted IND for Triphendiol
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2007
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2007
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Aug 2007
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Aug 2007
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2007
OVArian TUmor REsponse ('OVATURE') Trial Enrolls First U.S. Patient
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2007
New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Dec 2006
Marshall Edwards, Inc. Announces Initial Trial Sites, Principle Investigator for Phase III OVATURE Trial for Phenoxodiol
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Nov 2006
Marshall Edwards, Inc. Appoints Professor Bryan Williams as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2006
First Patient Treated in Phase III Ovarian Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2006
Marshall Edwards Achieves Special Protocol Assessment and Agreement With FDA on Phase III (Ovature Study) of Phenoxodiol as a Chemosensitizing Agent in Women With Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
OvaTure
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.